These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29075923)

  • 1. Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction.
    Genoud V; Quintana PG; Gionco S; Baldessari A; Quintana I
    J Thromb Thrombolysis; 2018 Jan; 45(1):66-76. PubMed ID: 29075923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of N-homocysteinylated albumin adducts.
    Genoud V; Castañon M; Lauricella AM; Quintana I
    Protein J; 2014 Feb; 33(1):85-91. PubMed ID: 24395118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma.
    Malinowska J; Nowak P; Olas B
    Thromb Res; 2011 Mar; 127(3):214-9. PubMed ID: 21186049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of homocysteine thiolactone results in the formation of Protein-Cys-S-S-homocysteinylation.
    Silla Y; Varshney S; Ray A; Basak T; Zinellu A; Sabareesh V; Carru C; Sengupta S
    Proteins; 2019 Aug; 87(8):625-634. PubMed ID: 30869815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and its thiolactone-mediated modification of fibrinogen affect blood platelet adhesion.
    Malinowska J; Olas B
    Platelets; 2012; 23(5):409-12. PubMed ID: 22010991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of erythropoietin structure by N-homocysteinylation affects its antiapoptotic and proliferative functions.
    Schiappacasse A; Maltaneri RE; Chamorro ME; Nesse AB; Wetzler DE; Vittori DC
    FEBS J; 2018 Oct; 285(20):3801-3814. PubMed ID: 30103295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Jamroz-Wiśniewska A; Bełtowski J; Bartosik-Psujek H; Wójcicka G; Rejdak K
    Int J Neurosci; 2017 Aug; 127(8):709-715. PubMed ID: 27671515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disturbance of hemostasis induced by hyperhomocysteinemia; the role of antioxidants.
    Malinowska J; Kolodziejczyk J; Olas B
    Acta Biochim Pol; 2012; 59(2):185-94. PubMed ID: 22577622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of homocysteine-thiolactone on plasma fibrin networks.
    Genoud V; Lauricella AM; Kordich LC; Quintana I
    J Thromb Thrombolysis; 2014 Nov; 38(4):540-5. PubMed ID: 24659173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-homocysteinylation induces different structural and functional consequences on acidic and basic proteins.
    Sharma GS; Kumar T; Singh LR
    PLoS One; 2014; 9(12):e116386. PubMed ID: 25551634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aronia melanocarpa extract suppresses the biotoxicity of homocysteine and its metabolite on the hemostatic activity of fibrinogen and plasma.
    Malinowska J; Babicz K; Olas B; Stochmal A; Oleszek W
    Nutrition; 2012 Jul; 28(7-8):793-8. PubMed ID: 22261575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels.
    Jakubowski H
    FASEB J; 1999 Dec; 13(15):2277-83. PubMed ID: 10593875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes].
    Malinowska J; Nowak P; Olas B
    Pol Merkur Lekarski; 2009 Nov; 27(161):413-8. PubMed ID: 19999808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin.
    Sauls DL; Warren M; Hoffman M
    Thromb Res; 2011 Jun; 127(6):576-81. PubMed ID: 21316742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMMERCIAL EXTRACT FROM ARONIA AS A MODULATOR OF ADHESIVE PROPERTIES OF FIBRINOGEN TREATED WITH HOMOCYSTEINE AND ITS THIOLACTONE IN VITRO.
    Olas B; Kontek B; Oleszek W; Stochmal A
    Acta Pol Pharm; 2016 Nov; 73(6):1609-1613. PubMed ID: 29634116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein homocysteinylation: a new mechanism of atherogenesis?
    Bełtowski J
    Postepy Hig Med Dosw (Online); 2005; 59():392-404. PubMed ID: 16106241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. May modifications of human plasma proteins stimulated by homocysteine and its thiolactone induce changes of hemostatic function of plasma in vitro?
    Olas B; Kołodziejczyk J; Malinowska J
    Gen Physiol Biophys; 2010 Jun; 29(2):186-93. PubMed ID: 20577030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of resveratrol on hemostatic properties of human fibrinogen and plasma during model of hyperhomocysteinemia.
    Malinowska J; Olas B
    Thromb Res; 2010 Nov; 126(5):e379-82. PubMed ID: 20869101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
    Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
    FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.